Romeo Roncucci
Inventor
Stats
- 14 US patents issued
- 14 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 14 US Patents Issued
- 14 US Applications Filed
- 213 Total Citation Count
- Feb 20, 1996 Most Recent Filing
- Apr 28, 1978 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
SANOFI, A FRENCH CORP. | 1
1 | 1984
1985 |
FARMITALIA CARLO ERBA S.P.A. | 1
1 | 1992
1996 |
FARMITALIA CARLO ERBA S.R.L. | 1
1 1 | 1991
1993 1994 |
Continental Pharma Incorporated | 1
1 | 1979
1985 |
CONTINENTAL PHARMA S.A. | 1
| 1978
|
NEWRON PHARMACEUTICALS S.P.A. | 1
1 1 | 1991
1993 1994 |
SANOFI | 1
1 1 2 1 | 1982
1983 1984 1985 1987 |
SANOFI 40 AVENUE GEORG V- 75008 PARIS | 1
| 1982
|
Inventor Addresses
Address | Duration |
---|---|
Milan, IT | Aug 17, 93 - Apr 13, 04 |
Paris, FR | Mar 09, 82 - Jan 10, 89 |
Rosiere-St. Andre, BE | Oct 02, 84 - Oct 02, 84 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 2 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 7 |
C07C: | ACYCLIC OR CARBOCYCLIC COMPOUNDS | 2 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
6719975 | 2004 | Anti-hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin | 0 |
5502079 | 1996 | N-phenylalkyl substituted .alpha.-amino carboxamide derivatives and process for their preparation | 29 |
5391577 | 1995 | N-phenylalkyl substituted .alpha.-amino carboxamide derivatives and process for their preparation | 30 |
5288855 | 1994 | Extracellular form of the human fibroblast growth factor receptor | 46 |
5236957 | 1993 | N-phenylalkyl substituted .alpha.-amino carboxamide derivatives and process for their preparation | 42 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.